Virometix AG
  • About us
    • Our Company
    • Management
    • Board of Directors
    • Advisory Board
    • Careers
  • Technology
    • Platform
    • IP
  • Pipeline
  • Partners
    • Collaborations
    • Grants & Awards
  • Newsroom
    • Press Releases
    • Events
    • Scientific Publications & Reviews
  • Contact
  • Search
  • About us
    • Our Company
    • Management
    • Board of Directors
    • Advisory Board
    • Careers
  • Technology
    • Platform
    • IP
  • Pipeline
  • Partners
    • Collaborations
    • Grants & Awards
  • Newsroom
    • Press Releases
    • Events
    • Scientific Publications & Reviews
  • Contact
  • Search

Collaborations

Virometix is offering co-development partnerships for vaccines against pneumococcal diseases, cervical cancer, respiratory viruses and other selected infectious diseases and chronic human diseases.

Virometix is also offering SVLP technology partnering and R&D collaborations in other application areas, including monoclonal antibody development, formulation of biologics and peptides and drug delivery.

For partnering enquiries, please contact us at [email protected]. Alternatively, you can meet us at the following upcoming conferences:

 

> Events

 


 

Grants & Awards

Our awards include the following

 

 

 

 
  • Virometix AG

    Wagistrasse 14
    8952 Schlieren
    Switzerland


    Tel. +41-43-433 86 60

    • LinkedIn
    • Privacy Statement
    • Site Notice
  • Oncometix Inc.

    c/o Lab Central
    700 Main Street North
    Cambridge, MA 02139
    USA

    Tel. +1-617-798 7233

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. more

Ok